FTC approves Medtronic acquisition of Covidien

SHARE FTC approves Medtronic acquisition of Covidien
SHARE FTC approves Medtronic acquisition of Covidien

NEW YORK — The U.S. Federal Trade Commission said Wednesday that it approved Medtronic’s $42.9 billion acquisition of Covidien after the medical device maker agreed to sell a business that makes a type of catheter used in veins.

Medtronic said it will sell Covidien’s drug-coated balloon catheter business to Colorado Springs, Colorado-based The Spectranetics Corp. shortly after its acquisition of Covidien closes. Medtronic expects the deal to close early next year. It still needs to be cleared by regulators and authorization from Ireland, where Covidien is based. Both companies’ shareholders also need to approve the acquisition.

Medtronic first announced the deal to buy Covidien in June.

Shares of Minneapolis-based Medtronic shares rose 69 cents to close at $73.48 Wednesday. U.S.-traded shares of Covidien rose $1.22 to close at $100.54. Spectranetics shares rose 29 cents to close at $32.29.

The Latest
A manager of the building where three women died during a stretch of warm temperatures said city rules required them to provide heat through June 1. “Nobody is going to freeze to death in Chicago in May,” said Ald. Brian Hopkins, who introduced an ordinance to ease that requirement.
Kadri has been the subject of racist social media posts since he was involved in a collision that knocked Blues goaltender Jordan Binnington out for the rest of the teams’ playoff series.
By focusing on the more mundane and also bringing a broader historical perspective, playwright August Wilson captured how the hope of the young was met by the weariness of those who had seen it all before.
Foles will back up veteran Matt Ryan, who was acquired in a trade with the Falcons for a third-round draft pick. Foles, the MVP of Super Bowl LII in 2018, spent two seasons with the Bears, starting seven games in 2020.